| Literature DB >> 24799898 |
Arini Nuran Idris1, Viji Chandran2, Syed Zulkifli Syed Zakaria2, Rahmah Rasat2.
Abstract
The aim of this study was to determine the behavioral outcome in children with CAH and to identify the risk factors that may influence it. Participants (aged 6-18 years) included 29 girls and 20 boys with CAH and unaffected siblings (25 girls and 17 boys). Psychological adjustment was assessed with parent reports on the Child Behavior Checklist (CBCL). Information about disease characteristics was obtained from medical records. Our study reveals that there was higher incidence of parent-reported problem of anxious/depressed and withdrawn/depressed behaviours, somatic complaints, social, thought, and attention problems, and rule-breaking, aggressive, internalizing, and externalizing behaviour among children with CAH compared to controls. The prevalence of internalizing behaviour problems was higher in CAH boys compared with that of controls. Psychosocial adjustment of girls with CAH was found to be similar to unaffected female controls and was within the normal population range. Family income may be associated with behavioral outcome. Glucocorticoid dose may reflect disease severity which may be associated with behavioral outcome. We conclude that internalizing behavioral problem was prevalent among boys with CAH reflecting maladaptive adjustment in coping with chronic illness. This highlighted the importance of psychological and social support for the patients and their families.Entities:
Year: 2014 PMID: 24799898 PMCID: PMC3995314 DOI: 10.1155/2014/483718
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Disease characteristics of CAH cases.
| Male | Female | |
|---|---|---|
| Age (in months) at starting treatmenta | 1.0 (1.5) | 0.5 (0.6) |
| Age in years at study entry | 11.6 (4.3)a | 11.9 (3.4)a |
| 11.5 (6–18)b | 12.0 (6–17)b | |
| Presentation at diagnosis | ||
| Salt wasting featuresc | 17 (85) | 23 (79) |
| No salt wasting featuresc | 3 (15) | 6 (21) |
| Ambiguous genitaliac | 0 | 29 (100) |
| Hypertensionc | 0 | 0 |
| Height SDS at the time of CBCLa | −1.1 (1.6) | −1.4 (2.2) |
| Serum 17-OHP in nmol/L at the time of CBCLa | 46.0 (182.1) | 8 (131.1) |
| Glucocorticoid dose in mg/m2/day near the time of CBCLa | 17.3 (4.9) | 14.4 (2.4) |
| Prader ratingc | ||
| 1 | 4 (14) | |
| 2 | 8 (28) | |
| 3 | 14 (48) | |
| 4 | 3 (10) | |
| Genitoplastyc | ||
| Nil | 4 (14) | |
| Clitoroplasty | 11 (38) | |
| Clitoroplasty and vaginoplasty | 14 (48) | |
| Age in years at the first genitoplastya | 2.3 (2.7) | |
| Serum testosterone in nmol/L of CAH girls at the time of CBCLa | 0.7 (3.3) |
aMean (standard deviation).
bMedian (range).
cFrequency (%).
CI: confidence interval.
Sociodemographic characteristics of study sample.
| Variable |
| Case | Control | Mean difference (95% CI) |
|
|
|
|---|---|---|---|---|---|---|---|
| Mean age at study entry in yearsa (SD) | |||||||
| Case | 49 | 11.8 (3.8) | — | 0.7 (0.8–2.2) | 0.871 (89) | — | 0.386 |
| Control | 42 | — | 12.5 (3.6) | ||||
| Genderb frequency (%) | |||||||
| Male | 37 | 20 (54) | 17 (46) | — | — | 0.00 (1) | 0.974 |
| Female | 54 | 29 (54) | 25 (46) | ||||
| Ethnicityb frequency (%) | |||||||
| Malay | 69 | 38 (55) | 31 (45) | — | — | 0.71 (1) | 0.678 |
| Others | 22 | 11 (50) | 11 (50) | ||||
| Mean family income in RMa (SD) | |||||||
| Case | 49 | 4383.7 (3287.6) | — | −138.4 (−1444.6, 1169.7) | −210 (89) | 0.834 | |
| Control | 42 | — | 4245.2 (2936.5) | ||||
| Parental marital statusc Frequency (%) | |||||||
| Married | 86 | 45 (52) | 41 (48) | — | — | 0.369 | |
| Single | 5 | 4 (80) | 1 (20) |
aIndependent t-test.
b χ 2 test for independence.
cFisher's exact test.
dSignificant P value <0.05.
SD: standard deviation; CI: confidence interval; RM: Ringgit Malaysia.
Mean T scores and mean differences for summary scales for cases and controls.
| Case | Control | Mean difference (95% CI) |
| |
|---|---|---|---|---|
| Internalizing | ||||
| Mean | 59.0 | 50.0 | 9.0 | <0.001* |
| SD | (10.5) | (9.7) | (4.8, 13.3) | |
| Externalizing | ||||
| Mean | 57.1 | 48.7 | 8.5 | <0.001* |
| SD | (8.7) | (9.1) | (4.7, 12.2) |
aANOVA.
SD: standard deviation; CI: confidence interval.
*Significant P value <0.05.
Clinical range T scores >63.
Proportions of CAH patients with clinical range scores on internalizing and externalizing scales compared to the controls.
| Male | Female | |||||||
|---|---|---|---|---|---|---|---|---|
| Case | Control |
|
| Case | Control |
|
| |
| Internalizing frequency (%) | 10 (50) | 2 (12) | 6.13 | 0.017 | 5 (17) | 4% (1) | 2.38 | 0.200 |
| Externalizing frequency (%) | 6 (30) | 1 (6) | 3.84 | 0.097 | 3 (10) | 4% (1) | 0.78 | 0.620 |
aFisher's exact test.
Significant P value <0.05.
Mean T scores and mean differences for syndrome scales for cases and controls.
| Case | Control | Mean difference |
| |
|---|---|---|---|---|
| Anxious-depressed | 57.8 (7.9) | 52.8 (3.7) | 5.0 (1.1, 8.9) | <0.001 |
| Withdrawn-depressed | 59.2 (8.5) | 54.1 (5.0) | 5.1 (0.7, 9.6) | 0.001 |
| Somatic | 61.4 (10.4) | 56.0 (7.3) | 5.4 (−0.3, 11.1) | 0.006 |
| Social | 59.7 (6.8) | 54.4 (4.2) | 5.2 (1.6, 8.8) | <0.001 |
| Thought | 58.0 (8.0) | 52.8 (4.0) | 5.2 (1.3, 9.1) | <0.001 |
| Attention | 60.9 (9.2) | 54.2 (5.2) | 6.7 (1.8, 11.5) | <0.001 |
| Rule-breaking | 57.2 (7.5) | 53.5 (4.9) | 3.7 (−0.4, 7.8) | 0.009 |
| Aggressive | 58.4 (7.8) | 53.2 (4.7) | 5.2 (1.2, 9.2) | <0.001 |
aANOVA.
SD: standard deviation; CI: confidence interval.
Statistically significant P value <0.05.
Clinical range T scores >69.
Percentage of CAH patients with clinical range scores on syndrome scales compared to the controls.
| Male | Female | |||||||
|---|---|---|---|---|---|---|---|---|
| Case | Control |
|
| Case | Control |
|
| |
| Anxious/depressed % ( | 15% (3) | 0% (0) | 2.78 | 0.23 | 10% (3) | 0% (0) | 2.74 | 0.24 |
| Withdrawn/depressed % ( | 20% (4) | 6% (1) | 1.57 | 0.35 | 14% (4) | 0% (0) | 3.72 | 0.11 |
| Somatic % ( | 35% (7) | 12% (2) | 2.70 | 0.13 | 7% (2) | 0% (0) | 1.79 | 0.49 |
| Social % ( | 5% (1) | 0% (0) | 0.87 | 1.00 | 7% (2) | 0% (0) | 1.79 | 0.49 |
| Thought % ( | 10% (2) | 0% (0) | 1.80 | 0.49 | 0% (0) | 0% (0) | — | 0.11 |
| Attention % ( | 15% (3) | 0% (0) | 2.78 | 0.23 | 14% (4) | 0% (0) | 3.73 | 0.34 |
| Rule-breaking % ( | 0% (2) | 6% (1) | 0.21 | 1.00 | 3.5% (1) | 0% (0) | 0.89 | 1.00 |
| Aggressive % ( | 25% (5) | 0% (0) | 4.91 | 0.05 | 3.5% (1) | 0% (0) | 0.87 | 1.00 |
aFisher's exact test.
Significant P < 0.05.
Correlations between psychological adjustment and age at study entry and family income in study subjects.
|
| Internalizing | Externalizing | Total | |
|---|---|---|---|---|
| Age at study entry | 91 | 0.07, ns | −0.14, ns | −0.07, ns |
| Family income | 91 | −0.30, 0.003* | −0.30, 0.005* | −0.38, <0.001* |
r: Pearson's correlation coefficient; ns: not significant.
*Significant P value <0.05 (2-tailed).
Correlations between psychological adjustment and disease characteristics in CAH patients.
|
| Internalizing | Externalizing | Total | |
|---|---|---|---|---|
| Age at diagnosis | 49 | −0.03, ns | −0.02, ns | 0.02, ns |
| Height SDs at study entry | 49 | 0.00, ns | 0.17, ns | 0.06, ns |
| Dose of glucocorticoid at study entry | 49 | 0.43, 0.002* | 0.41, 0.003* | 0.42, 0.003* |
| Serum 17-OHP at study entry | 49 | 0.10, ns | 0.02, ns | 0.10, ns |
r: Pearson's correlation coefficient; ns: not significant.
*Significant P value <0.05 (2-tailed).
Correlations between summary scales T scores and disease characteristics in CAH patients.
|
| Internalizing | Externalizing | Total | |
|---|---|---|---|---|
| Serum testosterone of CAH girls at study entry | 29 | −0.08, ns | 0.13, ns | 0.05, ns |
| Prader rating | 29 | −0.14, ns | 0.02, ns | −0.01, ns |
| Age at clitoroplasty or vaginoplasty | 25 | −0.00, ns | −0.17, ns | −0.08, ns |
r: Pearson's correlation coefficient; ns: not significant.
Simple linear regression analysis on factors correlated with mean T scores for summary scales.
| Independent variable | Dependent variable |
|
|
|
|
|
|---|---|---|---|---|---|---|
| Family income | Internalizing | 1.05 (0.39, 1.71) | 3.12 | 0.003* | 9.01 | 0.178 |
| Externalizing | 1.19 (0.45, 1.93) | 3.22 | 0.002* | 8.48 | 0.181 | |
| Glucocorticoid dose | Internalizing | 1.19 (0.45, 1.93) | 3.22 | 0.002* | 10.39 | 0.18 |
| Externalizing | 0.95 (0.33, 1.57) | 3.09 | 0.003* | 9.55 | 0.17 |
*Significant P value <0.05.
CI: confidence interval.